Keynote Presentation: Selecting Targeted Cancer Therapies and Clinical Trials with Computational... @Labroots
Keynote Presentation: Selecting Targeted Cancer Therapies and Clinical Trials with Computational...  @Labroots
Uploaded December 2025 | Updated November 2026, 6 hours ago
Presented By: Istvan Petak, MD, PhD



Speaker Biography: Dr. Istvan Petak is an international expert in precision oncology and molecular pharmacology of targeted therapies with 25+ years of experience. He is the founder and CEO of Genomate Health, Inc. Cambridge, MA, founder and co-founder of Oncompass Medicine, Budapest, HU, and adjunct professor at the Department of Pharmaceutical Sciences at the University of Illinois at Chicago (UIC) and Szechenyi University, Gyo-, He started his molecular pathology and signal transduction therapy career at Semmelweis University and St. Jude Children's Research Hospital (Memphis, TN). His main achievements are exploring the role of apoptotic pathways in individual drug sensitivity, pioneering molecular companion diagnostics of the EGFR gene in 2003, and implementing NGS (next-generation sequencing) in precision oncology in 2008. He is the lead inventor of a novel computational method, published in 2021, for standardized, personalized treatment recommendations that has won numerous recognitions from organizations, including DIGITALEUROPE and ASCO.



Webinar: Keynote Presentation: Selecting Targeted Cancer Therapies and Clinical Trials with Computational Reasoning



Webinar Abstract: Selecting the right targeted therapy or clinical trial for each cancer patient is one of modern oncology’s greatest challenges. Each tumor carries a unique combination of four to five actionable driver alterations, drawn from millions of possible molecular profiles across hundreds of cancer genes. Traditional evidence-generation models built on randomized trials for each unique profile cannot keep pace with this level of complexity.

In this presentation, Dr. Istvan Petak will demonstrate how computational reasoning, a next-generation deterministic form of artificial intelligence, can address this combinatorial explosion in cancer genomics. By integrating multidimensional molecular data with clinical and real-world evidence, computational reasoning systems can identify rational therapy options and clinical trial matches in real time, with explainable logic and reproducible results.

Through illustrative case examples, Dr. Petak will show how this approach transforms the precision oncology workflow from variant interpretation to treatment recommendation, enabling scalable, evidence-based personalization that augments both laboratory and clinical decision-making.

Learning Objectives:

1. Understanding the concept of precision oncology

2. Understanding the dimensionality problem of precision oncology

3. Understanding the use of different types of AI in precision oncology



Earn PACE Credits: 1. Make sure you’re a registered member of Labroots (labroots.com/virtual-event/clinical-diagnostics-research-2025/agenda) 2. Watch the webinar on YouTube or on the Labroots Website (labroots.com/virtual-event/clinical-diagnostics-research-2025/agenda) 3. Click Here to get your PACE credits (Expiration date –11/12/2026): (labroots.com/virtual-event/clinical-diagnostics-research-2025/continuing-education-credits) This link will be located in the CMS in the webinar CE tab – please enable third party PACE link



Labroots on Social:
Facebook: facebook.com/LabRootsInc
Twitter: twitter.com/LabRoots
LinkedIn: linkedin.com/company/labroots
Instagram: instagram.com/labrootsinc
Pinterest: pinterest.com/labroots
SnapChat: labroots_inc
Keynote Presentation: Selecting Targeted Cancer Therapies and Clinical Trials with Computational...Human-on-a-Chip for Translational PK/PD and Disease Modeling: Cardiac Ischemia, a Patient...Precision in Practice: Managing Indeterminate TB Testing with Quality SystemsUnlock Cell Therapy Potential with Customizable Cell Isolation and Enhanced T cell Activation...Lessons from the Classroom Using ELNs to Train the Next Generation of ScientistsMicrobiology of barrier components of a deep geological repository for used nuclear fuelClosing the Gap: Barriers to Diabetes Diagnosis in Real-World PracticeCombined JAK Inhibition and PD-1 blockade Improves Response in Lung Cancer PatientsBehind the Scenes: New HPLC Performance EnhancementsOpening - Proteomics to advance precision healthGynecologic Prognostic and Predictive Markers in the Era of Precision MedicineDouble your data, twice the insight: ProcartaPlex Dual Reporter assays
Labroots |

Keynote Presentation: Selecting Targeted Cancer Therapies and Clinical Trials with Computational...

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER